Five patients had blood glucose < 250 mg/dl at presentation (euglycemic DKA) [16, 53, 65, 71]; one was on SGLT2 inhibitor medication [16] while seven patients had gestational diabetes mellitus [53, 65, 70]. This evidence concerns the gene SLC5A2 and gestational diabetes.